Journal of the Academy of Public Health


img_example
June 1, 2026
Perspective

Estimating the Importance of Change in Patient-Reported Outcome Measures

Ron D. Hays, Steven P. Reise
Public Health News See All

Effect of a third COVID-19 vaccine dose on the ...

Shen at al., Vaccine

Immune-remodeling mRNAs expressing IRF8 or NIK ...

Gupta et al., Nature Biotechnology

Impact of introducing RTS,S/AS01E malaria vacci...

Mwapasa et al., The Lancet

Heterogeneous endocrine cell composition defines human islet functional phenotypes

Evans-Molina et al., Nature Communications

May 29, 2026
Perspective

Restoring Regulatory Fairness and Reclaiming Biomedical Leadership: ALS, Rare Disease Regulation, and the Future of Regenerative Medicine

Peter J. Pitts, Chaim Lebovitz
October 26, 2025
Literature Synthesis

Evidence that acetaminophen triggers autism in susceptible individuals has been ignored and mishandled for more than a decade.

William Parker, Paul T. Corrigan, Rachel Anderson, John P. Jones III ... R. Randal Bollinger
November 10, 2025
Literature Synthesis

BMJ’s Coverage of Kennedy’s Vaccine Reforms Amounts to Character Assassination

Peter C. Gøtzsche
September 9, 2025
Research Article

Identification of Potential Adverse Events After COVID-19 mRNA Vaccines in Danish Children Using Healthcare Registries

Stine S. Hoffmann, Sanne M. Thysen, Anton Pottegård, Christine S. Benn
October 3, 2025
External Article Review

External Article Review of: Drug development in psychiatry: 50 years of failure and how to resuscitate it

Peter C. Gøtzsche
September 10, 2025
Research Article

Sponsor-Level Compliance with ClinicalTrials.gov Reporting Requirements: A Comprehensive Analysis

Zakariyya Mughal, Thomas Luechtefeld, Jane Campbell Cashman, George F. Tidmarsh
March 3, 2025
External Article Review

External Article Review of: Vaccination and neurodevelopmental disorders: a study of nine-year-old children enrolled in Medicaid

Peter C. Gøtzsche
May 15, 2025
Perspective

Other Countries Are Not Paying Their Fair Share of the Cost of Biopharmaceutical Innovation – What Can the United States Do to Change That?

Richard Bagger, Peter J. Pitts

Sign up for content updates.